Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN107216326B enables mild synthesis of phenanthridine derivatives, ensuring high purity and supply chain stability for pharmaceutical intermediates globally.
Patent CN113307790B reveals a metal-free synthesis for 3-quinolyl-5-trifluoromethyl-1,2,4-triazoles, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN119330863A reveals air-stable synthesis reducing heavy metal use. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity standards.
Novel DMF-mediated synthesis of trifluoromethyl triazoles via patent CN114920707B. High efficiency, air-stable conditions ideal for API intermediates.
Patent CN111423381B reveals a mild palladium-catalyzed route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115286553B reveals nickel-catalyzed indole synthesis offering substantial cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN114195726B reveals robust CuCl catalyzed route for high-purity pharmaceutical intermediates. Achieve substantial cost reduction and supply chain reliability.
Novel one-step carbonylation cyclization for N-acyl indoles. High efficiency, broad substrate scope, cost-effective API intermediate manufacturing.
Novel Mo/Cu co-catalyzed method for high-purity triazoles. Reduces steps and improves yield for pharmaceutical manufacturing.
Patent CN114380741B details a green Ag-catalyzed method for 4-alkylated quinolines. Achieves high purity and yield in water, offering significant cost reduction in API manufacturing.
Patent CN108912076A details Pd-catalyzed synthesis offering high yield and regioselectivity for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN104961684A reveals a mild synthesis route for pyrazole intermediates. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN113683595B reveals sulfur-promoted synthesis eliminating heavy metals. Offers cost reduction in pharmaceutical intermediates manufacturing and scalable supply chain reliability.
Novel Pd-catalyzed carbonylation method for quinazolinones. High yield, scalable route for API intermediates like Rutaecarpine. Cost-effective manufacturing solution.
Novel metal-free route for trifluoromethyl pyrazole compounds. Room temperature reaction ensures cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115353511A details a mild Pd-catalyzed route for biheterocycles, offering significant cost reduction and supply chain reliability for API manufacturing.
Discover a novel metal-free one-pot synthesis for pyrimidoindazole compounds. This patent offers cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN117088826B enables visible light oxazole synthesis. Offers green chemistry benefits and supply chain stability for pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalysis enables high-yield, high-ee synthesis of anticancer intermediates, ensuring cost-effective and reliable supply chain solutions.
Patent CN114539198B reveals a novel Pd-catalyzed route for amide compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.